EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
10.43
+0.48 (4.82%)
Jul 9, 2025, 10:19 AM - Market open
EyePoint Pharmaceuticals Employees
EyePoint Pharmaceuticals had 165 employees as of December 31, 2024. The number of employees increased by 44 or 36.36% compared to the previous year.
Employees
165
Change (1Y)
44
Growth (1Y)
36.36%
Revenue / Employee
$339,648
Profits / Employee
-$889,582
Market Cap
717.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EYPT News
- 23 days ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - EyePoint Stock: Retaining My 'Risky Buy' Call - Pivotal Data Due Early 2026 - Seeking Alpha
- 5 weeks ago - EyePoint Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration - GlobeNewsWire
- 7 weeks ago - EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - EyePoint Pharmaceuticals, Inc. (EYPT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments - GlobeNewsWire
- 2 months ago - EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025 - GlobeNewsWire